Shanghai Kekai Biotechnology Co., Ltd.

[Shanghai China (Mainland) ]

  • 1st
Business Type:
Manufacturer
Year Established:
2015
Total Revenue:
US$501 Thousand - US$1 Million
Main Markets:
North America, South America, Eastern Europe, Southeast Asia, Africa, Oceania, Mid East, Eastern Asia, Western Europe

Company Description

Shanghai Kekai Biotechnology Co., Ltd. Is a biotech company founded in 2015 that focuses on the research and the production of recombinant proteins. Mainly dedicated to the research and development, production and sales of recombinant protein and monoclonal antibody biopharmaceuticals. It is a pioneer and leader in China' s biomedical industry and the first batch of certified biopharmaceutical companies in China and Shanghai. Our main products are Animal Origin Free recombinant carboxypeptidase B and recombinant trypsin, such as Hyaluronidase, Recombinant Enterokinase, Recombinant Protein G, Recombinant Protein A, Recombinant Trypsin, Recombinant Carboxypeptidase B, Chymotrypsin, recombinant lipase A, which are of high importance for the production of human recombinant insulin. Esepically for the recombinant Trypsin, we have Independent production workshop and manufactured through the world' s leading purification production process, with the characteristics of high activity and purity, and less impurities.

At present, we have about 4millon Annual output. and with the outbreak of domestic biomedicine, our production and sales are increasing exponentially every year.

In the future, we hope we will cooperation with more and more customers in the world.